Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

GNE myopathy is an ultra-rare, adult-onset muscle disorder caused by bi-allelic mutations in the GNE gene, which encodes a bifunctional enzyme responsible for the first two steps of sialic acid ...

A clinical trial has led to the approval of a treatment for patients with a rare, muscle-weakening disease called GNE myopathy. In order to treat an underserved population of patients with a rare ...

Fintel reports that on May 15, 2026, Freedom Broker upgraded their outlook for Genie Energy (NYSE:GNE) from Hold to Buy. Analyst Price Forecast Suggests 22.16% Upside As of May 14, 2026, the average ...

GNE is trading near the bottom of its 52-week range and near its 200-day simple moving average. Price change The price of GNE shares has increased $0.10 since the market last closed. This is a 0.71% ...

In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a ...